Ebba Nexo

Prof. Dr. Ebba Nexo

Aarhus Univ Hosp, Dept Clin Biochem, DK-8200 Aarhus N, Denmark
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2004 in Clinical Chemistry
Verified
Journal Article
Open access
HRHelga Refsum
Helga Refsum
DSDavid Smith
David Smith
PUPer M Ueland
Per M Ueland
Ebba NexoEbba Nexo
Ebba Nexo
RCRobert Clarke
Robert Clarke
JSJohn M Scott
John M Scott
Background: Measurement of plasma total homocysteine has become common as new methods have been introduced. A wide range of disorders are associated with increased concentrations of total homocysteine. The purpose of this review is to provide an international expert opinion on the practical aspects of total homocysteine determinations in clinical practice and in the research setting and on the relevance of total homocysteine measurements as diagnostic or screening tests in several target populations.Methods: Published data available on Medline were used as the basis for the recommendations. Drafts of the recommendations were critically discussed at meetings over a period of 3 years.Outcome: This review is divided into two sections: (a) determination of homocysteine (methods and their performance, sample collection and handling, biological determinants, reference intervals, within-person variability, and methionine loading test); and (b) risk assessment and disease diagnosis (homocystinuria, folate and cobalamin deficiencies, cardiovascular disease, renal failure, psychiatric disorders and cognitive impairment, pregnancy complications and birth defects, and screening of elderly and newborns). Each of these subsections concludes with a separate series of recommendations to assist the clinician and the research scientist in making informed decisions. The review concludes with a list of unresolved questions.

28 December 2003 in Age and Ageing
Verified
Journal Article
Open access
PDF file
RCRobert Clarke
Robert Clarke
JEJ. Grimley Evans
J. Grimley Evans
JSJ. Schneede
J. Schneede
Ebba NexoEbba Nexo
Ebba Nexo
CBC. Bates
C. Bates
JSJ. M. Scott
J. M. Scott
Objectives: to examine the prevalence of vitamin B12 deficiency and folate deficiency in later life in representative samples of the elderly population in the United Kingdom. Design: a population-based cross-sectional analysis of 3,511 people aged 65 years or older from three studies was used to estimate the age-specific prevalence of vitamin B12 deficiency and of folate deficiency. Vitamin B12 deficiency is conventionally diagnosed if serum vitamin B12 < 150 pmol/l (‘low vitamin B12’). We defined ‘metabolically significant vitamin B12 deficiency’ as vitamin B12 < 200 pmol/l and blood total homocysteine >20 μmol/l. Folate deficiency, which usually refers to serum folate <5 nmol/l, was defined as ‘metabolically significant’ if serum folate was 20 μmol/l. Results: the prevalence of vitamin B12 deficiency, whether defined as low vitamin B12 or metabolically significant vitamin B12 deficiency increased with age in all three studies, from about 1 in 20 among people aged 65–74 years to 1 in 10 or even greater among people aged 75 years or greater. The prevalence of folate deficiency also increased with age, and was similar to that for vitamin B12 deficiencies, but only about 10% of people with low vitamin B12 levels also had low folate levels. Conclusion: the high prevalence of vitamin B12 and folate deficiency observed in older people indicates a particular need for vigilance for deficiency of these vitamins. Reliable detection and treatment of vitamin deficiency could reduce the risk of deficiency-related disability in old age.

1 July 2011 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
Ebba NexoEbba Nexo
Ebba Nexo
EHElke Hoffmann-Lücke
Elke Hoffmann-Lücke
Approximately one-quarter of circulating cobalamin (vitamin B-12) binds to transcobalamin (holoTC) and is thereby available for the cells of the body

5 May 2005 in Calcified Tissue International
Verified
Journal Article
Closed access
PDF file
ALA. L. Lauridsen
A. L. Lauridsen
PVP. Vestergaard
P. Vestergaard
AHA. P. Hermann
A. P. Hermann
CBC. Brot
C. Brot
LHL. Heickendorff
L. Heickendorff
Ebba NexoEbba Nexo
Ebba Nexo

1 July 2011 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
EYElizabeth A Yetley
Elizabeth A Yetley
CPChristine M Pfeiffer
Christine M Pfeiffer
KPKaren W Phinney
Karen W Phinney
RBRegan Bailey
Regan Bailey
SBSheena Blackmore
Sheena Blackmore
MPMary Frances Picciano
Mary Frances Picciano
A roundtable to discuss the measurement of vitamin B-12 (cobalamin) status biomarkers in NHANES took place in July 2010. NHANES stopped measuring vit

1 May 2003 in The American Journal of Clinical Nutrition
Verified
Journal Article
Open access
PDF file
RCRobert Clarke
Robert Clarke
HRHelga Refsum
Helga Refsum
JBJacqueline Birks
Jacqueline Birks
JEJohn Grimley Evans
John Grimley Evans
CJCarole Johnston
Carole Johnston
JSJohn M Scott
John M Scott
Background: Vitamin B-12 deficiency is usually accompanied by elevated concentrations of serum total homocysteine (tHcy) and methylmalonic acid (MMA). Folate deficiency also results in elevated tHcy. Measurement of these metabolites can be used to screen for functional vitamin B-12 or folate deficiency. Objective: We assessed the prevalence of vitamin B-12 and folate deficiency in a population-based study (n = 1562) of older persons living in Oxford City, United Kingdom. Design: We postulated that, as vitamin B-12 or folate concentrations declined from adequate to impaired levels, tHcy (or MMA) concentrations would increase. Individuals were classified as being at high risk of vitamin B-12 deficiency if they had low vitamin B-12 (< 150 pmol/L) or borderline vitamin B-12 (150–200 pmol/L) accompanied by elevated MMA (> 0.35 μmol/L) or tHcy (> 15.0 μmol/L). Individuals were classified as being at high risk of folate deficiency if they had low folate (< 5 nmol/L) or borderline folate (5–7 nmol/L) accompanied by elevated tHcy (> 15 μmol/L). Results: Cutoffs of 15.0 μmol/L for tHcy and 0.35 μmol/L for MMA identified persons with normal or elevated concentrations. Among persons aged 65–74 and ≥ 75 y, respectively, ≈10% and 20% were at high risk of vitamin B-12 deficiency. About 10% and 20%, respectively, were also at high risk of folate deficiency. About 10% of persons with vitamin B-12 deficiency also had folate deficiency. Conclusion: Use of tHcy or MMA among older persons with borderline vitamin concentrations may identify those at high risk of vitamin B-12 deficiency who should be considered for treatment.